Tue, May 7, 2013
Mon, May 6, 2013
Sun, May 5, 2013
Fri, May 3, 2013
Thu, May 2, 2013
Wed, May 1, 2013
Tue, April 30, 2013
Mon, April 29, 2013
Sun, April 28, 2013
Fri, April 26, 2013
Thu, April 25, 2013
Wed, April 24, 2013
Tue, April 23, 2013
Mon, April 22, 2013
Sun, April 21, 2013
Fri, April 19, 2013
Thu, April 18, 2013
Wed, April 17, 2013
Tue, April 16, 2013

Levi &;; Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of Palomar Medical Te


  Copy link into your clipboard //health-fitness.news-articles.net/content/2013/ .. ary-duty-by-the-board-of-palomar-medical-te.html
  Print publication without navigation Published in Health and Fitness on by Market Wire
          🞛 This publication is a summary or evaluation of another publication

April 26, 2013 16:13 ET

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of Palomar Medical Technologies Inc. in Connection With Sale of Company to Cynosure Inc.

NEW YORK, NY--(Marketwired - Apr 26, 2013) - Levi & Korsinsky notifies investors of Palomar Medical Technologies Inc. ("Palomar" or the "Company") (NASDAQ: [ PMTI ]) of claims of breaches of fiduciary duty and other violations of state law against the board of directors of the Company in connection with the sale of the Company to Cynosure Inc. (NASDAQ: [ CYNO ]). A complaint was filed in Massachusetts state court.

Click here to learn how to join the action: [ http://zlk.9nl.com/palomar-medical-pmti/ ], or call: 877-363-5972. There is no cost or obligation to you.

Under the terms of the transaction, Palomar shareholders will receive $6.825 in cash and $6.825 in Cynosure common stock for each share of Palomar stock they own. The transaction has a total approximate value of $294 million. The claims concern whether the Palomar Board of Directors breached their fiduciary duties to stockholders by failing to adequately shop the Company before entering into this transaction and whether Cynosure Inc. is underpaying for Palomar shares, thus unlawfully harming Palomar stockholders. In particular, at least one analyst set a price target for Palomar stock at $14.50 per share.

If you own common stock in Palomar and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at [ jlevi@zlk.com ] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or [ http://zlk.9nl.com/palomar-medical-pmti/ ].

Levi & Korsinsky is a national firm with offices in New York, New Jersey, and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major securities lawsuits and have successfully recovered multimillion-dollar damages awards on behalf of investors. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.



Publication Contributing Sources